Cargando…
Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab
BACKGROUND: Asthma and bronchiectasis are different conditions that frequently coexist. The prevalence of bronchiectasis rises considerably in subjects with severe asthma (25%–51%). OBJECTIVE: We evaluated the clinical and biological efficacy of mepolizumab on our pilot population of severe uncontro...
Autores principales: | Carpagnano, Giovanna E, Scioscia, Giulia, Lacedonia, Donato, Curradi, Giacomo, Foschino Barbaro, Maria Pia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407514/ https://www.ncbi.nlm.nih.gov/pubmed/30881051 http://dx.doi.org/10.2147/JAA.S196200 |
Ejemplares similares
-
Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma–COPD overlap syndrome phenotype
por: Lacedonia, Donato, et al.
Publicado: (2017) -
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2021) -
Omalizumab as add‐on therapy in a patient with severe asthma and OSA
por: Scioscia, Giulia, et al.
Publicado: (2020) -
Physical Activity as a New Tool to Evaluate the Response to Omalizumab and Mepolizumab in Severe Asthmatic Patients: A Pilot Study
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2020) -
The Role of Airways 17β-Estradiol as a Biomarker of Severity in Postmenopausal Asthma: A Pilot Study
por: Scioscia, Giulia, et al.
Publicado: (2020)